EXPERIENCE OF SOLCOSERYL USE FOR THE TREATMENT OF VERTEBROGENIC RADICULO-ISHEMIC SYNDROME IN NEUROLOGY PRACTICE IN OUTPATIENT SETTINGS

The present article is concerned with mechanisms of vertebrogenic radiculo-ishemic syndrome (RIS), the experience of the solcoseryl use in comprehensive treatment of 82 patients with RIS compared with a control group of 85 patients with RIS. Among patients receiving solcoseryl, 70% achieved "moderate" and "good" total effect, whereas only 46% of patients in the control group achieved such effect. A similar pattern occurred with respect to individual components of RIS (pain syndrome and sensory-autonomic disorders). It was noted that solcoseryl is drug with high tolerability.

vertebrogenic radiculo-ishemic syndrome, degenerative-dystrophic diseases of the spine, solcoseryl